Johnson & Johnson (JNJ)

What if the market is simply pricing in a quarter that had already been priced out?

These pharmaceutical favorites continue to make progress on a number of fronts including a Covid-19 vaccine.

I would wait until the next down day, and there will be one.

That's the really good news about why we could bounce back so quickly from Thursday's debacle.

The administration will provide increased financial support to 5 pharmas working on Covid vaccines, and we must keep an eye on price action in this uncertain market.

We're cheering what may be an aberration, a bullish employment number. We'll take what it brings - a wholesale shift in what we're buying and what we're selling to fund it.

The Fed and Treasury are set on avoiding the mistakes that doomed us in the past, and we have to invest for this new market we're in now.

WDAY looks ready to break out as traders weigh wether markets are now overbought after this 2-day run.

So what's the narrative? Simple: the recession is ending, it turned out to be a V recession and recovery after all.

I've been long Merck for a long time, since way before this pandemic became part of our lives.

The return of NYSE floor traders is symbolic of the return to normalcy, as vaccine candidate manufacturers are scaling up for mass production.

Let's step back and look at this market that has abandoned all sorts of safety and went all in on the stocks of companies based on the Fed's words and a promising Moderna study.

I'm long this name, as I am several of the others involved. Will I add on a day like this?

Jerome Powell hit the airwaves with some words of caution and comfort. Nvidia is running into earnings.

The broad market may be soft for another week but if I find more stocks in a similar position as JNJ I won't see a reason to join the bear camp.

Trump administration taps former GlaxoSmithKline exec as head of vaccine task force, and how I'm playing Walmart and Datadog.

Let's look at the stocks that will get crushed and that you can't touch right now.

I have always liked the aggressive management.

Don't pigeon hole yourself into a certain pattern of action when you see opportunities.

I'm staying long this name, and I'm staying long PFE and JNJ, and I'm staying long GILD and ABT. You know why? Because I'm optimistic.

The bullish reversal pattern is appearing not just in single names, but also in whole sectors.

PFE is collaborating with German drugmaker BioNTech in the effort to find a well tolerated, effective vaccine.

There was a mild increase in trading volume at the New York Stock Exchange, but it was a rotational shift.

It's imperative that people get back to work, so we have this great compromise -- let's see how it might play out.

Stop apologizing, don't surrender to the gloom and tell your story with sympathy but with glory, and don't make us feel like it's a mistake to own shares in your company.

Trading volumes dropping on major indexes, U.K. teams begin human trials on a Covid-19 vaccine, and the U.S. Senate wants another stimulus package addition.

Welcome to the new era. Social distancing is not without risks, but it is as good as it gets.